Acne Vulgaris
📧 Sign up to get email alerts when something new happens for Acne Vulgaris.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2023-03-30FDA Approved: SEYSARA — Supplemental Application (Almirall, LLC)
FDA approved a supplemental application for SEYSARA (sarecycline hydrochloride) from Almirall, LLC.
-
FDA approval · 2023-03-24FDA Approved: CLARAVIS — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
The FDA approved a supplemental application for CLARAVIS (isotretinoin) from Teva Pharmaceuticals USA, Inc., under the approved ANDA, indica…
-
FDA approval · 2023-03-24FDA Approved: ABSORICA — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
The FDA approves a supplemental application for ABSORICA (isotretinoin) from Sun Pharmaceutical Industries, indicating a regulatory update r…
-
FDA approval · 2023-03-24FDA Approved: ISOTRETINOIN — Supplemental Application (Upsher-Smith Laboratories, LLC)
FDA approved Upsher-Smith Laboratories' supplemental application for isotretinoin.
-
FDA approval · 2023-03-24FDA Approved: ISOTRETINOIN — Supplemental Application (Upsher-Smith Laboratories, LLC)
FDA approved a supplemental application for isotretinoin filed by Upsher-Smith Laboratories, LLC.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2023-03-24FDA Approved: CLARAVIS — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
FDA approved a supplemental application for CLARAVIS (isotretinoin) by Teva Pharmaceuticals USA, Inc., under ANDA076135.
-
FDA approval · 2023-03-24FDA Approved: ZENATANE — Supplemental Application (BluePoint Laboratories)
FDA approved a supplemental application for Zenatane (isotretinoin) by BluePoint Laboratories (ANDA 202099).
-
FDA approval · 2023-03-24FDA Approved: ISOTRETINOIN — Supplemental Application (Amneal Pharmaceuticals NY LLC)
FDA approved a supplemental application for isotretinoin from Amneal Pharmaceuticals NY LLC.
-
FDA approval · 2023-03-24FDA Approved: ISOTRETINOIN — Supplemental Application (Actavis Pharma, Inc.)
FDA approved a supplemental application for isotretinoin by Actavis Pharma, Inc. for the generic product.
-
FDA approval · 2023-03-20FDA Approved: TAZAROTENE — Original Application (Solaris Pharma Corporation)
The FDA approved a generic version of tazarotene (topical retinoid) from Solaris Pharma Corporation through an Original Abbreviated New Drug…
-
FDA approval · 2023-03-02FDA Approved: ADAPALENE — Supplemental Application (Alembic Pharmaceuticals Inc.)
The FDA approved a supplemental application for adapalene from Alembic Pharmaceuticals, confirming approval of a generic adapalene product.
-
FDA approval · 2023-01-05FDA Approved: TRETINOIN — Original Application (NORTHSTAR RX LLC)
The FDA approved NorthStar RX LLC's original ANDA for tretinoin, enabling a generic topical retinoid product to reach the market.
-
FDA approval · 2022-12-07FDA Approved: DOXYCYCLINE — Original Application (Par Health USA, LLC)
FDA approved a generic doxycycline product under an original new drug application by Par Health USA, LLC (ANDA216690).
-
FDA approval · 2022-10-31FDA Approved: AZELAIC ACID — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
The FDA approved a supplemental application for azelaic acid from Sun Pharmaceutical Industries, Inc.
-
FDA approval · 2022-10-06FDA Approved: CLARAVIS — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
FDA approved Teva's supplemental application for CLARAVIS (isotretinoin), a supplemental approval for the product.
-
FDA approval · 2022-10-06FDA Approved: AMNESTEEM — Supplemental Application (Mylan Pharmaceuticals Inc.)
FDA approved a supplemental application for AMNESTEEM (isotretinoin) submitted by Mylan Pharmaceuticals, updating labeling for its acne trea…
-
FDA approval · 2022-10-06FDA Approved: CLARAVIS — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
FDA approved a supplemental application for CLARAVIS (isotretinoin) to Teva Pharmaceuticals USA, Inc.
-
FDA approval · 2022-10-06FDA Approved: ZENATANE — Supplemental Application (BluePoint Laboratories)
FDA approved a supplemental application for Zenatane (isotretinoin) submitted by BluePoint Laboratories.
-
FDA approval · 2022-10-06FDA Approved: ISOTRETINOIN — Supplemental Application (Amneal Pharmaceuticals NY LLC)
FDA approved a supplemental application for isotretinoin filed by Amneal Pharmaceuticals NY LLC, resulting in updated labeling for isotretin…
-
FDA approval · 2022-10-06FDA Approved: ABSORICA LD — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
The FDA approves a supplemental application for ABSORICA LD (isotretinoin) filed by Sun Pharmaceutical Industries, resulting in updated labe…
-
FDA approval · 2022-10-06FDA Approved: ISOTRETINOIN — Supplemental Application (Upsher-Smith Laboratories, LLC)
The FDA has approved a supplemental application for isotretinoin from Upsher-Smith Laboratories, LLC.
-
FDA approval · 2022-10-06FDA Approved: ISOTRETINOIN — Supplemental Application (Actavis Pharma, Inc.)
The FDA approved a supplemental application for isotretinoin submitted by Actavis Pharma, Inc. The approval pertains to changes in labeling …
-
FDA approval · 2022-10-06FDA Approved: ISOTRETINOIN — Supplemental Application (Mayne Pharma)
The FDA approved a supplemental application for isotretinoin from Mayne Pharma.
-
FDA approval · 2022-10-06FDA Approved: ABSORICA — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
The FDA approved a supplemental application for ABSORICA (isotretinoin) submitted by Sun Pharmaceutical Industries, Inc.
-
FDA approval · 2022-10-06FDA Approved: ISOTRETINOIN — Supplemental Application (Upsher-Smith Laboratories, LLC)
FDA approved a supplemental application for isotretinoin submitted by Upsher-Smith Laboratories, LLC, indicating an approved change related …